EPIndicator ApS: Financial statements 2025
CVR: 45409368
Source: annual report 2025, Danish Business Authority
12/02/2025 – 31/12/2025
EPIndicator ApS (CVR 45409368) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 144,774 and a net result of DKK -252. Equity in the 2025 report amounted to DKK 39,748. The solvency ratio was 100%.
- Gross Profit
- DKK 144,774
- Profit/Loss
- DKK -252
- Equity
- DKK 39,748
- Total Assets
- DKK 39,748
How creditworthy is EPIndicator ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of February 12, 2025, Søren Hofman Rosenkranz is registered as director of EPIndicator ApS.
As of February 12, 2025, SR MedTech ApS is registered as an owner of EPIndicator ApS with an ownership share of 100%.
EPIndicator ApS was founded on February 12, 2025.
About EPIndicator ApS
EPIndicator ApS is a Danish company of the type Anpartsselskab based in Ruds Vedby, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Hofman Rosenkranz. The company is owned by SR MedTech ApS. In 2025, the company reported a gross profit of DKK 144,774 and a net result of DKK -252. Equity in the 2025 report amounted to DKK 39,748.